Angel Investors · Bayer’s patented drug · Brand and Trademark Monitoring in Social Media · brand confusion · Business Consultant Singapore · Business Due Diligence Report · Business Idea | Patent · Business in India · Business News · Business Stock · Buying or Selling a Website · competition law expert · Competition Laws in India · Compulsory licensing India · Corporate Company · Doing Business in India · Entrepreneur · generic version drug · incorporate legal entity · Intellectual Property · Intellectual Property India · Licensing & Syndication · Possible Legal Issues · Start New Business in India

Secretarial Services | Incorporation of a Company | Filing of Petition and Applications

Secretarial Services

Angel Investors · Brand and Trademark Monitoring in Social Media · Brand Protection · Business Idea | Patent · Business in India · Business News · Business Stock · Buying or Selling a Website · Competition Commission of India (CCI) · competition law expert · Competition Laws in India · Compulsory licensing India · Contract Drafting Law Firm in India · Corporate Company · Data Protection · Doing Business in India · Entrepreneur · Entrepreneurs · incorporate legal entity · India Business Entity Types · initial public offering (IPO) · Internet Law Attorney for Website Agreements and Contracts · IP due-diligence · IP India Law · Patent VC funding · protecting business idea · Start New Business in India · Start ups · Trademarks and Venture Capital Investments · Venture Capital Funding · Venture Capital Investments

Securities Laws Business Consultancy in India | Consultancy Services for Legal Provisions and Compliances under Securities and Exchange Board of India (SEBI)

Securities Laws Business Consultancy in India | Consultancy Services for Legal Provisions and Compliances under Securities and Exchange Board of India (SEBI)

Bayer’s patented drug · Business News · Compulsory licensing India · generic version drug · Legal News

India Allows Compulsory Licensing Of Bayer’s Anti-Cancer Drug Sorafenib To NATCO Pharma

The globally watched case related to an Indian pharma company's request to the country's patent office for a compulsory license to make a generic version of Bayer's patented drug to treat liver and kidney cancer has been settled on March 13, 2012. In a first-of-its-kind ruling in one of the world's fastest growing pharma markets,… Continue reading India Allows Compulsory Licensing Of Bayer’s Anti-Cancer Drug Sorafenib To NATCO Pharma